Scarlet fever

AB1_SCARLET_FEVER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A38 Hospital discharge: ICD-9 — 03[4] Hospital discharge: ICD-8 — 03[4] Hospital discharge: excluded ICD-9 — 034[0] Hospital discharge: excluded ICD-8 — 034[0] Cause of death: ICD-10 — A38 Cause of death: ICD-9 — 03[4] Cause of death: ICD-8 — 03[4] Cause of death: excluded ICD-9 — 034[0] Cause of death: excluded ICD-8 — 034[0] 2 out of 7 registries used, show all original rules.	264
4. Check minimum number of events None	264
5. Include endpoints None	264
6. Filter based on genotype QC (FinnGen only)	258

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_BACTERIAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_SCARLET_FEVER
CONTROL_EXCLUDE	AB1_OTHER_BACTERIAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A38
HD_ICD_9	03[4]
HD_ICD_8	03[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	034[0]
HD_ICD_8_EXCL	034[0]
COD_MAINONLY
COD_ICD_10	A38
COD_ICD_9	03[4]
COD_ICD_8	03[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	034[0]
COD_ICD_8_EXCL	034[0]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Scarlet fever based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4075	1777	2286
Only index persons	3185	1380	1805
Unadjusted period prevalence (%)
Whole population	0.06	0.05	0.06
Only index persons	0.06	0.05	0.07
Median age at first event (years)
Whole population	7.01	6.65	7.16
Only index persons	7.59	7.19	7.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	258	144	114
Unadjusted period prevalence (%)	0.05	0.05	0.05
Median age at first event (years)	10.52	9.03	12.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
264: Matched controls
2640

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

03419

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina NUD

+∞

98.2

A38

ICD-10 Finland

Scarlet fever

+∞

89.8

03417

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina suspecta

+∞

46.2

0341A

ICD-9 Finland

Streptococcal sore throat and scarlatina, Scarlatina[SCARLATINA STREPTOCOCCUS BETAHAEMOLYTICUS,RYHMÄ-A]

+∞

16.8

0341X

ICD-9 Finland

Streptococcal sore throat and scarlatina, Scarlatina[SCARLATINA STREPTOCOCCUS BETAHAEMOLYTICUS,MUU]

+∞

15.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

27.4

13.6

A46

ICD-10 Finland

Erysipelas

5.6

11.3

03410

ICD-8 Finland

Streptococcal sore throat and scarlet fever, Scarlatina cum complicatione

+∞

8.4

A41.9

ICD-10 Finland

Sepsis, unspecified

+∞

7.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.1

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

127

3.33

9.45

2.8

2.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

5.15

8.49

1.7

1.6

—

(3023368) Bacteria identified in Blood by Culture

297

2.32

6.98

4.3

3.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

179

1412

1.83

4.95

8.4

6.0

77.83

75.76

u/l

0.27

169

1335

(3022217) INR in Platelet poor plasma by Coagulation assay

621

1.80

4.71

8.8

7.1

1.09

1.12

inr

0.27

209

(40761536) Microorganisms panel - Urine sediment

156

2.35

4.64

4.7

2.7

—

(3021589) Normoblasts [#/volume] in Blood

126

913

1.73

4.54

13.6

7.2

0.00

e9/l

0.80

106

744

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

120

859

1.73

4.51

7.2

4.9

10.43

11.32

umol/l

0.42

111

826

(3024561) Albumin [Mass/volume] in Serum or Plasma

625

1.75

4.34

8.0

3.8

36.77

37.62

g/l

0.84

601

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

4.05

4.06

1.9

3.4

54.93

54.44

0.06

(3030905) Polymorphonuclear cells [#/volume] in Blood

4.05

4.06

1.9

3.3

3.79

3.69

e9/l

0.07

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.73

4.01

2.0

1.7

—

(3042936) Bacteria identified in Isolate by Culture

199

2.06

3.77

1.7

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

293

1.87

3.60

1.5

1.4

146.67

603.81

titre

4.30

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

5.44

3.54

2.1

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.68

3.46

2.0

1.8

—

(3022145) Colonoscopy Study observation

192

2.01

3.41

1.5

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

200

1.99

3.37

1.8

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

4.05

3.33

3.1

1.8

17.76

17.26

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

682

1.61

3.30

14.1

4.7

1.21

1.22

mmol/l

1.33

636

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.42

3.27

1.7

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

463

1.66

3.11

1.5

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

175

1462

1.58

3.08

5.2

3.5

8.30

8.20

mm/h

0.05

161

1380

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.96

3.04

1.9

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

524

1.60

2.86

2.1

2.3

52.77

58.55

u/l

0.77

498

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.67

2.81

2.1

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.67

2.81

2.1

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

262

1.77

2.73

1.8

1.6

425.53

27572457.47

pmol/l

0.50

243

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

566

1.56

2.69

4.7

2.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

127

1012

1.49

2.62

5.5

3.6

6.59

6.34

mmol/l

0.48

115

925

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.31

2.60

1.6

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

364

1.65

2.59

3.4

2.0

2.74

2.73

mg/l

0.02

313

(3029937) Albumin [Presence] in Urine by Test strip

492

1.58

2.58

5.2

2.9

0.00

0.01

estimate

0.50

178

(40760892) CBC W Ordered Manual Differential panel - Blood

120

952

1.48

2.50

9.3

5.7

—

(4035726) Immunohistochemistry procedure

103

2.13

2.49

1.2

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

177

1.85

2.43

4.8

1.7

2.57

2.53

g/l

0.15

167

(3026782) Osmolality of Urine

313

1.65

2.39

3.9

2.0

471.45

552.05

mosm/kgh2o

1.28

255

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

553

1.53

2.39

2.9

2.8

20.40

23.62

ng/l

0.16

273

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.20

2.37

1.1

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

183

1593

1.48

2.27

4.6

3.8

14.64

14.45

pmol/l

0.47

168

1490

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.96

2.26

1.9

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

3.18

2.24

8.1

1.3

8.88

9.54

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

3.18

2.24

8.1

1.3

4.69

4.93

kpa

—

(3051611) Lipemic interference index of Serum or Plasma

5.64

2.22

5.2

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.40

2.20

1.6

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

519

1.50

2.17

4.2

2.6

2.34

2.36

mmol/l

0.56

471

(3019309) Folate [Moles/volume] in Red Blood Cells

184

1.78

2.16

2.2

1.6

1452.38

1117.00

nmol/l

1.37

148

(3023520) Reticulocytes [#/volume] in Blood

2.15

2.12

3.6

2.9

64.54

69.40

e9/l

0.14

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.27

2.11

1.8

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.97

2.09

1.2

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

759

1.44

2.09

14.3

5.2

1.21

1.22

mmol/l

0.96

651

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

5.07

2.08

1.8

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.07

2.08

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

133

1.88

2.07

4.0

4.6

0.00

0.23

—

(3021440) Promyelocytes/100 leukocytes in Blood

141

1.85

2.05

3.8

4.4

0.25

0.08

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

402

1.53

2.05

1.9

1.8

0.70

0.91

mg/l

0.41

291

(3002179) Metamyelocytes/100 leukocytes in Blood

135

1.86

1.99

3.9

4.2

0.29

0.32

—

(3026493) Urate [Moles/volume] in Serum or Plasma

431

1.51

1.98

2.7

2.3

5481.47

1350.69

umol/l

0.36

400

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.39

1.98

1.9

1.3

—

(3018418) pH of Serum or Plasma

449

1.50

1.97

4.5

3.0

7.39

7.40

0.53

(40768441) Liver Pathology biopsy report

4.61

1.95

1.6

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

4.61

1.95

2.4

2.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

4.61

1.95

2.4

2.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

4.61

1.95

2.4

1.6

—

(3013115) Eosinophils [#/volume] in Blood

126

1046

1.39

1.90

9.0

5.7

0.19

e9/l

0.11

115

931

(3019198) Lymphocytes [#/volume] in Blood

127

1056

1.39

1.89

8.7

5.4

1.98

2.05

e9/l

0.45

117

948

(3044889) 12 lead EKG panel

150

1286

1.39

1.84

3.3

2.9

—

(3017181) Myelocytes/100 leukocytes in Blood

147

1.77

1.81

3.8

4.3

1.62

0.48

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

582

1.43

1.81

1.8

2.1

—

(3001604) Monocytes [#/volume] in Blood

122

1016

1.37

1.77

8.8

5.4

0.55

e9/l

0.04

112

893

(3004588) Protein electrophoresis panel - Serum or Plasma

2.28

1.76

1.0

1.9

—

(3006315) Basophils [#/volume] in Blood

122

1017

1.37

1.75

8.9

5.5

0.04

e9/l

0.47

112

894

(1616796) Gas panel - Central venous blood

2.72

1.74

8.9

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

197

1.65

1.72

1.8

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

221

2039

1.51

1.71

16.2

8.6

139.41

139.76

mmol/l

1.90

214

1989

(3044640) Blood type and Crossmatch panel - Blood

515

1.43

1.71

2.7

1.8

—

(3026008) Bacteria identified in Urine by Culture

418

1.46

1.70

2.8

2.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.85

1.66

5.3

2.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

105

861

1.36

1.65

2.8

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.43

1.63

1.2

1.3

4.80

3.23

u/ml

—

(3030467) Casts [#/volume] in Urine by Automated count

439

1.44

1.63

5.3

2.3

0.13

0.28

e6/l

1.22

313

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.62

1.62

2.2

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.55

1.61

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.38

1.60

1.1

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.74

1.59

1.4

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

3.04

1.59

7.5

3.1

13.30

7.59

u/ml

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

3.04

1.59

1.0

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

130

1.76

1.59

3.3

2.4

14035.73

3695.39

u/l

0.36

(3021879) Hepatitis B virus core Ab [Presence] in Serum

187

1.62

1.53

1.3

1.6

—

(36304419) Bacteria [Presence] in Urine

445

1.42

1.51

5.2

2.3

—

(3009343) pH of Capillary blood

125

1.74

1.48

24.5

3.3

7.43

7.41

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.97

1.47

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.16

1.46

2.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

395

1.43

1.45

2.8

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

152

1336

1.32

1.44

6.4

3.3

—

(3042631) Mycobacterium sp identified in Specimen

3.16

1.44

1.6

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

2.29

1.41

5.0

1.9

—

(40768793) Breast Pathology biopsy report

2.29

1.41

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

2.64

1.37

1.5

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

220

2054

1.43

1.34

16.5

8.7

3.94

3.95

mmol/l

0.07

211

1995

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

770

1.32

1.33

4.5

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

205

1894

1.37

1.31

12.1

7.6

92.18

92.76

ml/min/173m2

0.15

170

1531

(3035350) Ketones [Presence] in Urine by Test strip

114

972

1.30

1.31

4.7

2.7

0.00

estimate

-0.00

186

(3021601) Nitrite [Presence] in Urine by Test strip

114

972

1.30

1.31

6.1

3.9

0.00

estimate

-0.00

183

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

138

1.65

1.31

1.6

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

493

1.36

1.30

5.2

2.4

11.43

42.48

e6/l

1.57

360

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.04

1.29

2.4

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.81

1.29

2.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.81

1.29

2.4

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

139

1.64

1.28

1.8

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

115

985

1.30

1.27

4.8

2.8

0.10

0.00

estimate

0.49

171

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2.01

1.24

2.5

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.66

1.22

2.4

3.3

—

(40768443) Skin Pathology biopsy report

1.87

1.21

1.3

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.08

1.16

1.5

1.1

—

(3003694) ABO and Rh group [Type] in Blood

641

1.31

1.16

1.7

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

2.53

1.15

1.2

1.3

—

(3022313) Gas panel - Capillary blood

1.71

1.13

32.6

3.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

351

1.38

1.11

1.4

1.3

2.18

6.81

u/ml

1.40

150

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.98

1.09

1.3

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

236

2250

1.46

1.09

12.3

7.8

30.03

28.98

u/l

0.34

226

2196

(3017143) Hepatitis C virus Ab [Presence] in Serum

326

1.38

1.08

1.5

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

723

1.28

1.07

3.8

2.4

74.95

73.03

nmol/l

0.29

671

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.15

1.06

1.1

—

(3000991) Gas panel - Venous blood

122

1.60

1.06

28.2

6.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

500

1.31

1.05

1.6

1.61

1.52

mmol/l

0.23

446

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1.99

1.04

5.0

2.8

3.57

3.22

g/l

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.09

1.03

3.1

2.0

23.80

22.98

mmol/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

202

1889

1.30

1.00

5.2

4.3

1.74

2.40

mu/l

0.55

190

1789

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

2.20

0.98

3.4

2.8

14.00

19.35

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.98

0.0

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

131

1168

1.24

0.97

10.7

7.7

4.00

3.85

e9/l

0.30

121

1014

(3011397) Hemoglobin [Presence] in Urine by Test strip

415

1.32

0.95

5.0

2.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

370

1.33

0.94

1.4

1.3

28.80

28.95

iu/ml

0.00

127

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

2.25

0.94

2.2

2.3

—

(3034770) Mitochondria Ab [Titer] in Serum

1.78

0.91

1.6

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

178

1.45

0.90

1.2

1.3

199.96

185.49

iu/ml

0.04

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.75

0.87

8.5

5.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.70

0.86

1.6

2.1

—

(40761535) Cells panel - Urine sediment

105

1.56

0.84

2.6

2.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

165

1.43

0.81

3.7

6.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

253

1.35

0.80

2.2

1.8

—

(3025941) Bacteria identified in Stool by Culture

123

1.50

0.80

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.84

0.79

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.60

0.76

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

222

2123

1.29

0.76

14.9

8.7

21.48

19.36

mg/l

0.43

184

1567

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.72

0.76

1.0

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

218

0.67

0.75

1.1

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.82

0.73

1.7

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1.82

0.73

2.4

1.6

—

(3021901) Oxygen saturation in Capillary blood

2.02

0.73

4.0

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

1.50

0.73

2.1

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

330

1.29

0.72

1.5

1.3

19.38

20.39

nmol/l

0.16

295

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1.77

0.72

1.0

1.1

116.57

113.74

—

(3012544) pH of Venous blood

135

1.44

0.71

22.8

4.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.94

0.71

1.0

1.2

—

(40758558) Short blood count panel - Blood

490

1.24

0.69

8.9

5.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

303

0.74

0.68

1.4

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.54

0.67

1.4

1.2

—

(3018095) Leukocytes [#/volume] in Urine

605

1.21

0.67

6.2

3.0

27.08

151.74

e6/l

0.94

392

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1.80

0.66

1.0

2.2

0.00

g/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.80

0.66

1.0

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1.80

0.66

1.0

2.2

0.00

g/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

190

1.35

0.65

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.68

0.61

1.4

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

563

1.21

0.61

1.4

1.3

0.48

1.40

u/ml

2.26

166

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

256

1.28

0.60

4.6

2.4

1.94

2.50

e6/l

0.17

135

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

(3015736) pH of Urine

805

1.18

0.59

4.3

2.6

5.71

5.87

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.73

0.58

1.0

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.73

0.58

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

193

1838

1.19

0.57

3.4

3.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

378

1.23

0.57

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.68

0.57

1.0

2.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

510

1.20

0.57

1.5

1.3

2.20

2.18

g/l

0.04

326

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.64

0.56

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

590

1.18

0.53

4.0

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

571

1.18

0.53

1.6

1.7

91.88

95.96

pmol/l

0.36

301

(3002385) Erythrocyte distribution width [Ratio]

201

1927

1.18

0.52

18.2

10.9

13.99

14.19

0.27

195

1907

(3020682) Albumin/Creatinine [Ratio] in Urine

403

1.20

0.50

4.0

3.4

9.41

6.16

mg/mmol

0.25

272

(21494755) Public health laboratory ask at order entry panel

385

0.81

0.50

1.3

1.4

—

(3019225) pH of Specimen

119

1.37

0.49

3.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

255

1.24

0.48

1.9

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

102

1.39

0.48

1.6

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

164

1.30

0.48

6.7

5.6

102.62

104.74

mmol/l

0.78

164

(40768804) Tissue Pathology biopsy report

721

1.16

0.48

1.8

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.47

0.47

1.1

1.9

—

(4200892) Spirometry reversibility

129

1.34

0.47

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

201

1.27

0.47

1.7

2.0

—

(3012516) Albumin [Mass/volume] in Urine

387

1.20

0.46

3.0

2.8

111.25

204.64

mg/l

0.21

264

(3013512) EKG study

387

1.20

0.46

3.4

2.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.41

0.45

1.1

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

608

1.16

0.45

1.8

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

323

1.21

0.44

4.2

2.6

128.73

70.12

ug/g

0.62

255

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1.62

0.43

1.0

2.4

0.00

1.42

g/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1.62

0.43

1.0

2.2

0.00

g/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.40

0.43

1.4

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.42

0.42

3.9

4.1

0.88

0.65

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1.45

0.42

1.0

1.1

1.35

4.76

u/ml

—

(40768797) Stomach Pathology biopsy report

232

1.23

0.42

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.39

0.42

3.0

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.41

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.41

0.0

1.9

—

(40761511) CBC panel - Blood by Automated count

232

2264

1.20

0.40

14.8

8.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

261

1.21

0.40

4.7

2.2

0.21

0.97

e6/l

2.61

140

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

2.53

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

375

0.83

0.39

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

170

0.75

0.39

2.2

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.38

0.39

1.2

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.31

0.37

1.4

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

185

1782

1.13

0.36

4.8

4.1

38.66

38.09

mmol/mol

0.31

172

1713

(3009508) Creatinine [Moles/volume] in Urine

512

1.14

0.36

3.4

2.7

8.73

8.97

mmol/l

0.12

467

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.40

0.35

1.7

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

295

0.83

0.34

1.8

2.2

0.66

0.62

ug/l

—

136

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

166

1593

1.11

0.34

4.2

2.8

41.94

42.04

u/l

0.01

156

1544

(36660697) Celiac disease serology panel - Serum

211

1.20

0.33

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

287

1.17

0.32

3.5

2.9

1465.41

570.84

ng/l

0.63

227

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

187

1925

0.90

0.29

3.8

3.5

5.87

5.72

mmol/l

0.63

172

1820

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

199

2042

0.90

0.29

4.0

3.6

1.40

1.44

mmol/l

0.85

187

1963

(3022621) pH of Urine by Test strip

103

1.28

0.28

5.5

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.30

0.28

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.66

0.26

1.2

—

(3000330) Specific gravity of Urine by Test strip

1.24

0.25

1.7

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.28

0.24

1.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

1.17

0.24

2.2

2.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

115

1.23

0.24

2.1

1.6

294.14

343.04

mu/l

0.25

104

(3000764) Benzodiazepines [Presence] in Urine

179

0.83

0.24

2.5

2.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

134

1.21

0.23

2.3

2.2

63.14

83.25

ml/min/173m2

—

(3027008) Opiates [Presence] in Urine

178

0.83

0.22

2.5

2.0

—

(3028300) Cannabinoids [Presence] in Urine

178

0.83

0.22

3.2

2.0

—

(3027944) Amphetamines [Presence] in Urine

178

0.83

0.22

2.5

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

156

0.82

0.22

1.2

1.3

—

(3008898) HLA-B27 [Presence]

126

1.20

0.21

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1509.20

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

226.09

—

(3019832) Treponema pallidum Ab [Presence] in Serum

365

1.11

0.21

1.6

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

1.51

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

7.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

26.49

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

1.69

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.21

0.0

10.8

—

56.00

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.78

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.20

0.0

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.20

0.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.20

0.0

2.1

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.20

0.0

1.9

—

(1761868) Lipid panel - Serum or Plasma

100

957

1.07

0.19

2.8

2.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

436

1.09

0.18

2.4

2.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.17

0.18

3.6

4.0

1.13

1.77

—

(3000494) Fungus identified in Specimen by Culture

215

1.13

0.17

1.2

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.75

0.17

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.74

0.17

1.0

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

942

1.06

0.16

3.8

2.4

97.91

94.10

ug/l

0.08

895

(3019150) Specific gravity of Urine by Refractometry

449

1.08

0.16

5.2

2.7

1.02

kg/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

130

0.84

0.16

2.0

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.16

0.15

1.2

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

128

0.85

0.14

2.8

1.8

—

(3002256) Pathology report gross observation

220

1.10

0.12

1.3

1.2

—

(1002224) Polysomnography panel

137

0.87

0.12

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

476

1.06

0.11

2.6

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.17

0.11

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

271

1.08

0.10

1.8

2.9

893.69

235.31

ng/l

0.52

163

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.04

0.09

2.4

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.07

0.08

1.0

1.1

—

13.96

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.05

0.08

1.0

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

204

2061

0.96

0.08

4.3

3.8

2.83

2.91

mmol/l

0.80

189

1972

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.78

0.08

1.0

1.2

—

(4034850) Laboratory test

1.06

0.08

5.1

7.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

207

2050

1.05

0.08

4.0

3.6

4.69

4.79

mmol/l

0.83

192

1975

(3003327) Ova and parasites identified in Stool by Light microscopy

1.08

0.07

1.9

1.6

—

(3016879) Cocaine [Presence] in Urine

163

0.92

0.07

2.5

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

111

0.90

0.06

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

196

1970

0.98

0.02

3.7

3.3

1.46

1.32

mmol/l

1.26

183

1882

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

379

0.97

0.02

1.5

1.8

1.33

1.35

0.05

360

(1001926) Buprenorphine [Presence] in Urine by Screen method

136

0.95

0.00

2.5

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

144

1.04

0.00

1.0

—

(3000492) Spirometry study

234

1.03

0.00

1.7

1.4

—

(3007461) Platelets [#/volume] in Blood

246

2462

0.99

0.00

21.4

13.2

260.09

257.39

e9/l

0.29

239

2412

(3009542) Hematocrit [Volume Fraction] of Blood

246

2459

1.01

0.00

21.6

13.1

40.67

41.35

1.08

237

2358

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.03

0.00

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.03

0.00

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.03

0.00

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.03

0.00

1.6

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

134

0.97

0.00

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

246

2465

0.97

0.00

21.4

13.2

7.51

6.58

e9/l

0.65

239

2408

(3026361) Erythrocytes [#/volume] in Blood

246

2465

0.97

0.00

21.4

13.1

4.57

4.64

e12/l

1.38

239

2413

(3011288) Drugs identified in Urine by Screen method

115

0.95

0.00

3.2

3.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3045716) Anion gap in Serum or Plasma

0.00

0.0

1.0

—

10.29

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.97

0.00

1.5

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

188.24

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.02

0.00

1.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.92

-0.00

1.5

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.2

—

20.62

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.95

-0.00

1.5

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

-0.00

0.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

-0.00

0.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.97

-0.00

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.92

-0.00

11.9

7.6

1.34

1.56

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.93

-0.00

12.3

7.6

0.79

0.72

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.01

-0.00

4.3

3.8

124.57

140.09

g/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.96

-0.00

1.0

1.1

—

9.10

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3014271) Vancomycin [Susceptibility]

0.00

-0.00

0.0

2.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.96

-0.00

12.6

7.8

91.41

94.24

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.98

-0.00

2.8

1.9

—

(3019060) Gas panel - Arterial blood

0.99

-0.00

1.9

2.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

0.92

-0.00

2.1

2.0

0.13

0.08

e6/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

619.17

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.95

-0.00

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3045414) Leukocytes [Presence] in Urine

1.01

-0.00

1.9

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_SCARLET_FEVER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_SCARLET_FEVER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_SCARLET_FEVER – Scarlet fever

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Scarlet fever

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints